Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
At 72, Kathie Lee Gifford says aging isn’t what she expected. 'The golden years? It’s a lie.’ - 2India’s delayed climate plan sets modest emission target
- 3Gulf aluminum output tumbles on Iran war
- 4The Most Moving TED Talks You Want to Watch
- 5Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
- Shadow Cats: The Elusive Leopards Surviving Against Impossible Odds
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Track down the Ideal Weight reduction Methodology for Your Way of life
- Medtronic has 'significant firepower' for multiple acquisitions, executives say
- Journey Travel Objections for Your Next Experience
- Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
